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Abstract
The cellular entry of viruses represents a critical area of study, not only for viral tropism, but also because viral entry
dictates the nature of the immune response elicited upon infection. Epidemic keratoconjunctivitis (EKC), caused by
viruses within human adenovirus species D (HAdV-D), is a severe, ocular surface infection associated with corneal
inflammation. Clathrin-mediated endocytosis has previously been shown to play a critical role in entry of other HAdV
species into many host cell types. However, HAdV-D endocytosis into corneal cells has not been extensively studied.
Herein, we show an essential role for cholesterol rich, lipid raft microdomains and caveolin-1, in the entry of HAdV-
D37 into primary human corneal fibroblasts. Cholesterol depletion using methyl-β-cyclodextrin (MβCD) profoundly
reduced viral infection. When replenished with soluble cholesterol, the effect of MβCD was reversed, allowing
productive viral infection. HAdV-D37 DNA was identified in caveolin-1 rich endosomal fractions after infection. Src
kinase activity was also increased in caveolin-1 rich endosomal fractions after infection, and Src phosphorylation and
CXCL1 induction were both decreased in caveolin-1-/- mice corneas compared to wild type mice. siRNA knock down
of caveolin-1 in corneal cells reduced chemokine induction upon viral infection, and caveolin-1-/- mouse corneas
showed reduced cellular entry of HAdV-D37. As a control, HAdV-C2, a non-corneal pathogen, appeared to utilize the
caveolar pathway for entry into A549 cells, but failed to infect corneal cells entirely, indicating virus and cell specific
tropism. Immuno-electron microscopy confirmed the presence of caveolin-1 in HAdV-D37-containing vesicles during
the earliest stages of viral entry. Collectively, these experiments indicate for the first time that HAdV-D37 uses a lipid
raft mediated caveolin-1 associated pathway for entry into corneal cells, and connects the processes of viral entry
with downstream proinflammatory cell signaling.
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Introduction
Human adenoviruses (HAdVs) cause a broad range of
infections at mucosal sites [1]. Additionally, HAdV vectors are
widely used for the study of cellular processes, and are chosen
as gene and vaccine delivery vehicles for clinical use. A
shortcoming of HAdVs in therapy for human diseases is their
intrinsic tendency, as with infection by naturally occurring
HAdVs, to induce innate immune responses and inflammation
[2,3]. One potential mechanism for HAdV induced inflammation
can be found in the process of viral entry, in which cellular
components involved in viral internalization directly induce
subsequent inflammatory gene expression by infected cells
[4–7]. Therefore, to understand basic mechanisms of HAdV
induced inflammation, and to mitigate complications of
adenoviral gene therapy, it is important to understand modes of
HAdV entry into various cell types.
Endocytosis is a multi-step process that involves
internalization of macromolecules and particles into specific
transport vesicles derived from a cell’s plasma membrane.
Clathrin mediated endocytosis is a well studied endocytic
pathway used by both enveloped and non-enveloped viruses
[8].The cell surface is abundantly endowed with other
components that allow detection and response to external
stimuli. Lipid rafts represent one of the major constituents of
the cell membrane, contain a heterogeneous population of
proteins, and act as centers for downstream cell signaling.
Caveolae are a special type of lipid raft that by electron
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microscopy appear as uncoated, flask-shaped invaginations of
the plasma membrane, and are responsible for uptake and
efflux of cholesterol esters. Caveolar, lipid raft mediated
endocytosis plays an important role in cell adhesion and growth
[9,10]. Caveolins are the major integral membrane protein of
caveolae [11] and include three types with a similar molecular
weight of 22 kDa [12,13]. Caveolin-1 and -2 are found in most
cell types, while caveolin-3 is present only in muscle cells.
Knockout of the gene for caveolin-1 in mice also reduces
caveolin-2 expression, and leads to loss of morphologically
defined caveolae [14]. Caveolae-like structures were identified
as possible pathways of viral entry for SV40 in 1989 [15],
however, SV40 entry via caveolae was recently disputed [16].
In addition to SV40, caveolae and lipid rafts have been
implicated in the entry of filovirus [17], human enterovirus [18],
echovirus [19] and human immunodeficiency virus [20,21],
among others [22–26]. Importantly, the specific means of host
cell entry by viruses appears to be dependent on the type of
cell and its state of activation, and may be redundant [27,28].
Signaling molecules are an integral part of the host immune
response to viral infection, and recent studies have shown a
role for cell signaling in viral entry [29–32] and viral replication
[33]. For adenoviruses, viral attachment to specific integrins
activates PI3K which in turn activates the small GTPases, Rac
and Cdc42 [34] . Inhibition of cell signaling can drastically
reduce virus infection [35,36]. SV40 entry is regulated by at
least five different kinases [37]. Virus attachment to cells can
induce lipid raft formation by clustering of specific surface
proteins and lipids. Interestingly, many viruses bind
glycophosphatidylinositol (GPI)-anchored proteins and
gangliosides, associated with the outer leaflet of the plasma
membrane, and this may lead directly to activation of cellular
kinases [30], adding to increasing evidence that virus binding to
lipid rafts specifically initiates intracellular signaling.
For the entry of adenoviruses, existing evidence suggests
entry begins with a requisite binding of the adenovirus capsid
fiber knob to a cellular receptor such as the coxsackie
adenovirus receptor (CAR) [38], CD46 [39,40], or in particular
for viruses causing epidemic keratoconjunctivitis, GD1a glycan
[41]. Initial binding is followed by a secondary interaction
between the arginine-glycine-aspartic acid (RGD) motif in the
viral capsid penton base and cellular integrins αvβ3, αvβ5, and
αVβ1 [42–45] This secondary interaction is thought to induce a
host cell signaling cascade resulting in clathrin mediated
endocytosis [46–48], and possibly, activation of the rab5
dependent classical endosomal pathway [49]. Herein, we show
that HAdV-D37, an etiologic agent of epidemic
keratoconjunctivitis, enters primary human corneal fibroblasts
predominantly via lipid rafts and caveolae, suggesting both
redundancy and cell specificity in mechanisms of adenoviral
entry.
Results
Cell and virus specific infection
To test whether viral entry is cell and/or virus specific as
previously shown for HAdV-C [50], we directly compared
pathways of infection in human corneal fibroblasts and A549
cells using HAdV-D37 and HAdV-C2. Individual confocal image
slices were loaded to measure co-localization pixels (Amira
5.2.2) in cells (green: caveolin-1 or LAMP1, a late endosomal
marker associated with conventional endosomes [51], red:
Cy3-labeled HAdV-D37). In human corneal cells, Cy3-labeled
HAdV-D37 co-localized to a greater degree with caveolin-1
than with LAMP1 (p=.0068), while in A549 cells HAdV-37
predominantly co-localized with LAMP1 (p=.0025), indicating
an entry pathway other than caveolae (Figures 1A and B).
HAdV-C2, not known to infect the cornea, failed to infect
corneal cells in culture, and in A549 cells co-localized
predominantly with caveolin-1 (p=.02). (Figures 1A and B).
Cholera toxin B subunit (CTXB) has been used to track and
identify lipid rafts. To further examine the role of lipid raft
microdomains in HAdV-D37 entry, we treated corneal cells with
both Cy3-labeled virus and 488-CTXB, and tracked their
cellular localization over time (Figure 1C). Co-localization of
virus and CTXB was observed in the cell membrane at 30 min,
cytoplasm at 60 min, and perinuclear region at 90 min,
supporting a role for caveolin-1 and lipid rafts in HAdV-D37
entry into corneal cells.
Cholesterol Dependent HAdV-D37 Cell Entry
In order to directly determine a role for cholesterol-laden lipid
rafts in HAdV-D37 entry, primary corneal cells were pretreated
with MβCD (5 mM) to deplete cholesterol prior to infection with
Cy3-labeled HAdV-D37. Earlier studies showed an essential
role for both integrins and Src kinase in HAdV entry
[31,35,45,46,52]. Therefore, control pretreatments also
included an RGD-containing 15-mer (50 μM) designed to
match the amino acid sequence in the HAdV-D37 penton base
(DAVP(RGD)NYASAAEA) [53,54], in order to block integrin
aggregation, and its KGE-containing 15-mer control
(DAVP(KGE)NYASAAEA), otherwise identical to the RGD 15-
mer. The chemical PP2 (10 μM) was used to inhibit Src kinase
activity. At both 30 min and 1 hr post infection, viral entry
appeared nearly completely blocked by pretreatment with
either MβCD or RGD, and partially by PP2, but not by KGE
(Figure 2A). Replenishment of cholesterol (0.4mg/ml in 0.2mM
MβCD) for 1 hr appeared to restore both normal cell
morphology and viral entry, as assessed by confocal
microscopy (Figure 2B). Western blot analysis of detergent free
lipid raft preparations at 1 hr post infection revealed increased
caveolin-1 in lipid rafts from virus infected cells as judged
collectively in fractions 4, 5 and 6 (Figure 2C). Caveolin-1 was
seen at much lower levels and only in the 5th fraction of mock
infected cells. In cells that were MβCD treated prior to virus
infection, caveolin-1 was reduced. We also observed increased
phospho-Src (pSrc) in virus infected cell fractions 5 and 6.
Reductions in both caveolin-1 and pSrc were observed in RGD
pretreated cells, whereas PP2 pretreatment reduced only pSrc
and not caveolin-1 (Figure 2C). These results suggest a
relationship between caveolin-1 and Src in HAdV-D37 entry.
HAdV-D37 enters corneal cells via caveosomes
Our results indicate that cholesterol depletion in corneal cells
presents an impediment to entry of HAdV-D37 past the cell
membrane. To investigate the type of endosome used in
HAdV Entry and Caveolin-1
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Figure 1.  HAdV-37 uses caveolin-1 to enter human corneal cells.  A. Human corneal and A549 cells grown on slide chambers
were infected with Cy3-labeled HAdV-D37 (red). Cells were then stained with caveolin-1 or LAMP1 antibodies as indicated followed
by alexa-fluor488 (green) secondary antibodies. Original magnification: 63X. Insets represent similarly magnified squares from each
photomicrograph. B. Three random frames from different experiments were chosen in masked fashion from each experiment (n=3)
to quantify co-localization using Amira 5.2.2. In A549 cells, HAdV-C2 co-localized predominantly with caveolin-1, while HAdV-D37
co-localized with LAMP1 (*p=.02 and *p=.0025, respectively). In corneal cells (CC), Cy3-labeled HAdV-D37 co-localized
predominantly with caveolin-1 (*p=.0068), and HAdV-C2 was not seen. Students t test was used for all comparisons. C. Human
corneal cells were grown in chamber slides, Cy3-labelled HAdV-D37 and 488-Cholera Toxin B (CTXB) were added to the cells on
ice and then warmed to 37°C, and incubated for 30, 60, and 90 min, prior confocal microscopy. HAdV-D37 (red) co-localized with
CTXB (green) at all time points. At 30 min after warming, HAdV-D37 and CTXB co-localization was observed at the cell membrane,
at 60 min in the cytoplasm, and at 90 min at the perinuclear region.
doi: 10.1371/journal.pone.0077462.g001
HAdV Entry and Caveolin-1
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Figure 2.  Cholesterol depletion impedes viral entry.  A. Human corneal cells grown on slide chambers were pretreated with
MβCD (5 mM), RGD-containing 15-mer (50 μM), a KGE-containing 15-mer otherwise identical to the RGD 15-mer (50 μM), or the
Src kinase inhibitor PP2 (10 μM), and then infected with Cy3-labeled HAdV-D37 (red). MβCD pretreatment prevented virus from
entering the cells both at 30 min and 1 hr post infection as compared to no pretreatment. RGD and PP2 reduced entry as compared
to KGE treated or untreated cells. Co-staining with alexa-fluor488 phalloidin (green). Original magnification: 63X. Insets represent
similarly magnified squares from each photomicrograph. B. Cholesterol was added to MβCD pretreated cells for one hr and then
infected with Cy3-labeled HAdV-D37. Confocal microscopy revealed entry of viruses into the corneal cells. C. Detergent free lipid
raft preparations in HAdV-D37 infected corneal cells, pretreated with MβCD, RGD 15-mer, KGE 15-mer, or PP2, and lysed at 1 hr
post infection, followed by immunoblotting for caveolin-1 or phosphorylated Src (pSrc). Blots show increased caveolin-1 and pSrc
upon viral infection, but reduced expression with cholesterol depletion or blocking of integrin aggregation (MβCD and RGD
treatment, respectively). PP2 treatment did not effect caveolin-1 levels in infected cells, but did reduce pSrc.
doi: 10.1371/journal.pone.0077462.g002
HAdV Entry and Caveolin-1
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HAdV-D37 entry, flotation gradient fractionation of post nuclear
supernatants was performed to separate different endosomal
compartments [55]. Upon viral infection, fractions 4-6
maximally expressed LAMP1 indicating the presence of late
endosomes [56], while fractions 9-11 were enriched with
caveolin-1, indicating the presence of caveolae (Figure 3A).
When the blots were stripped and reprobed, the caveolin-1
containing fractions were found to also contain pSrc. RAB5, a
marker for early endosomes [57] was observed in fractions
14-16 upon viral infection, but was not evident in the fractions
expressing pSrc. We confirmed Src activation in fractions 10
and 11 using a Src kinase assay in which substrate
fluorescence and kinase activity are inversely proportional
(Figure 3B). These results suggest that a pathway mediated by
caveolin-1, and involving Src kinase, is an important route of
HAdV entry into human corneal cells. MβCD pretreatment
altered the fractionation of caveolin-1, and resulted in reduced
identification of endosomal markers (Figure 3A). However, we
cannot exclude alternative possible effects of MβCD on clathrin
mediated mechanisms, as previously shown [58,59].
Real-time PCR was then performed to amplify HAdV-D37
genomic E1A nucleotide sequence [54] in order to determine
the presence of viral DNA in different endosomal fractions.
Upon infection of corneal cells, significantly more viral DNA
was present in the fraction 10, containing caveolin-1and pSrc,
than in fraction 6, which was abundant in LAMP1 (Figure 3C)
Figure 3.  HAdV-D37 uses primarily caveolin-1 to enter corneal cells.  A. Endosomal purification was performed on postnuclear
extracts from corneal cells at 1 hr post infection in 62%, 35% and 25% sucrose solution. Fractions were immunoblotted for
caveolin-1 (Cav 1), pSrc, RAB5, and LAMP1. B. Src kinase assay was performed on endosomal fraction #’s 5-11. In this assay,
fluorescence is inversely proportional to kinase activity. As shown, fractions 10 and 11, which previously showed increased
caveolin-1, also demonstrated greater Src kinase activity. C. Fractions that had maximum expression of LAMP1 (#6) and caveolin-1
(#10) were then subjected to real time PCR. For both fractions, the quantity of viral DNA was reduced by MβCD pretreatment (*p<.
05). Cholesterol replenishment resulted in restoration of E1A expression (*p<.05). There was no difference in E1A expression
between virus infected cells and those pretreated with MβCD but replenished with cholesterol and then virus infected. The data
presented is representative of four experiments each run in duplicate.
doi: 10.1371/journal.pone.0077462.g003
HAdV Entry and Caveolin-1
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(fraction 6 vs. fraction 10 in virus infected cells: p=.0027).
MβCD pretreatment reduced viral DNA content in both
endosomal fractions (p<.05, both comparisons). Viruses can
often circumvent artificial barriers to cell entry by use of
alternate entry pathways [50,60,61]. However, in our study,
MβCD pretreatment reduced the presence of viral DNA in both
the caveolin-1 containing fraction and in the LAMP1 containing
fraction. We also examined for the presence of viral DNA in
lipid raft fractions from MβCD treated cells when replenished
with cholesterol, as compared to those treated with MβCD
alone prior to viral infection. In lipid raft fractions from MβCD
treated, cholesterol replenished cells, E1A content was
equivalent to that from cells not treated with MβCD prior to
infection (Figure 3C).
Caveolin-1 and cholesterol are necessary for viral entry
Caveolin-1 is a critical protein to caveolae [62], and upon
reduction in caveolin-1 expression, cells lose the ability to form
caveolae. We prepared a siRNA oligo against caveolin-1 that
by real-time PCR reduced its expression in corneal cells to
~5% of normal (p=.0002, Figure 4A). Western blot analysis
after siRNA transfection also showed reduction in caveolin-1
protein as compared to untransfected or control siRNA (Figure
4B). Specificity of the caveolin-1 siRNA was validated by
showing expression of unrelated protein kinase C was not
reduced compared to control (data not shown). However,
HAdV-D37 infection of corneal cells after caveolin-1 knock
down by siRNA reduced IL-8 expression by ~ 50% (p=.0001,
Figure 4C).
Using the mouse adenovirus keratitis model [5,63,64], we
then analyzed the role of caveolin-1 in viral infection. Cy3-
labeled HAdV-D37 was injected into the corneal stroma of
caveolin-1 -/- mice on a C57BL/6J background or wild type
C57BL/6J controls. By confocal microscopy performed at 30
min, 1 hr, and 24 hr post infection, viral entry, but not viral
attachment, appeared markedly reduced in caveolin-1 -/- as
compared to wild type mice at these time points (Figure 5A).
Western blot analysis of wild type and caveolin-1-/- mice
corneas after infection revealed increased pSrc in wild type
corneas at 1 and 24 hr post infection, compared to caveolin-1
-/- mice, suggesting that caveolin-1 is necessary for Src
activation after infection (Fig, 5B). Similarly, upon viral
infection, CXCL1 protein expression was reduced in caveolin-1
-/- mice as compared to wild type mice (p=.0001, Figure 5C).
These results suggest that caveolin-1 is important to viral entry,
kinase activation, and subsequent chemokine expression.
Src kinase has been previously shown critical to both HAdV-
D37 entry [35] and inflammatory consequences of infection of
human corneal cells [35,52,65–67]. Data presented above
further suggest that Src may play an important role in lipid raft
mediated HAdV entry into corneal cells. Therefore, we applied
the Src kinase inhibitor PP2 (10 μM) to the mouse adenovirus
keratitis model. When injected 30 min prior to HAdV-D37
infection, PP2 reduced corneal inflammation as assessed by
histology 4 days post infection (Figure 5D) and also reduced
CXCL1 expression by ELISA at 16 hr post infection (p<.05,
Figure 5E), while the PP2 solvent DMSO alone did not reduce
inflammation or CXCL1 expression. Taken together, these data
suggest HAdV-D37 enters corneal cells at least in part via
caveolae, in an integrin dependent and Src kinase mediated
pathway.
Ultrastructure of caveolin-associated viral entry
Caveolae are submicroscopic, membrane associated
vesicles found abundantly in some but not all mammalian cells.
A Caveola has a characteristic flask or bulb-shaped
appearance [68–70], without the obvious coat of clathrin
pits[ 71]. Initially, SV40 was reported to use the caveolar
pathway to enter cells [15,72], but was later observed to use a
caveolae independent pathway [16,60,73]. Each caveolae
contains approximately 140-150 caveolin-1 molecules [74]. To
confirm caveolin associated viral entry into corneal fibroblasts,
we performed ultrastructural studies with and without viral
infection (Figure 6). Electron micrographs of uninfected
fibroblasts demonstrate abundant membrane associated
vesicles, visible as flask shaped invaginations of the cell
membrane (Figure 6A). Within 1 hr after HAdV-D37 infection,
viruses were seen in some of these Caveola-like structures
(Figure 6B-D). In some tissue sections, it appeared that
caveolae were fusing to form caveolar vesicles (caveosomes)
as reported earlier [75]. Viruses also accumulated in these
presumed caveosomes (Figure 6D). In order to confirm that the
membrane associated vesicles seen ultrastructurally are
indeed caveolae, we applied immuno-electron microscopy with
primary antibodies against caveolin-1 or clathrin, and
secondary antibody bound to protein-A nanogold. Membrane-
associated vesicles in human corneal fibroblasts labeled well
with antibody against caveolin-1 (Figure 6E). Within 30 min
after viral adsorption, many caveolin-1 expressing vesicles
were seen to contain virus (Figure 6F). The size of the
caveolin-1 containing vesicles in corneal cells ranged from
~80-140nm in diameter (data not shown). Therefore some
vesicles appeared able to accommodate the ~ 90 nm diameter
adenovirus. Notably, clathrin staining vesicles in the same cells
were much less abundant and no clathrin staining vesicles
were seen to contain virus (data not shown). These results
confirm that HAdV-D37 uptake into human corneal fibroblasts
occurs in vesicles containing caveolin-1.
Discussion
Endocytosis is used by pathogens as a gateway to cellular
entry. The specific pathway of entry seems to be host and
pathogen specific [76]. The most well studied mechanism of
receptor-mediated entry is clathrin-dependent endocytosis.
Most previous reports suggest that HAdVs use clathrin
mediated endocytosis for cellular entry [77,78], with
macropinocytosis as an alternate pathway [77,79–81].
Caveolae are ubiquitous on the surface of cells, particularly in
fibroblasts [82], and appear large enough to accommodate
human adenoviruses [83–85], which typically measure ~ 90 nm
in diameter. Recently, HAdV-C was shown to utilize lipid raft
mediated, caveolar endocytosis in non fibroblast cell lines
[50,61]. Because of our longstanding interest in pathogenesis
of HAdVs in the human cornea, we sought to test viral entry in
primary human corneal fibroblasts. We used two cell types,
HAdV Entry and Caveolin-1
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Figure 4.  Caveolin-1 and cholesterol dependent viral entry.  siRNA and scrambled (sc)RNA were generated and transfected
into human corneal cells. A. Real-time RT-PCR for caveolin-1 mRNA confirmed successful reduction of caveolin-1 message (~95%)
as compared to scRNA transfected cells (*p=.0002). B. Western blot showed reduced expression of caveolin-1 in caveolin-1 specific
siRNA treated cells (right lane) as compared to untransfected and uninfected cells (left lane) or scRNA transfected, virus infected
cells (middle lane) C. IL-8 mRNA expression after HAdV-D37 infection was reduced to almost 50% by caveolin-1 siRNA
transfection, compared to scRNA (*p=.0001).
doi: 10.1371/journal.pone.0077462.g004
HAdV Entry and Caveolin-1
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primary fibroblasts cultured directly from human donor corneas,
and as control, A549 cells, a human alveolar epithelial cell line
that was previously shown to support HAdV-1 virion production
[86] and commonly used for the culture of HAdVs. Our results
clearly demonstrate caveolin-1 associated entry into corneal
cells by the highly cornea-tropic HAdV-D37. In contrast, HAdV-
D37 entry into A549 cells was less robust and appeared to
predominantly involve the LAMP1 pathway. As an additional
control, we also tested the entry of HAdV-C2, a non corneal
pathogen, but the degree of entry into human corneal cells was
too low to permit quantitative analysis. Caveolae mediated
entry of another non-enveloped DNA virus, SV40, is
controversial [16,60,73], and in the absence of caveolin-1,
SV40 still successfully enters cells [60], suggesting redundant
and alternative mechanisms. However, in corneal stromal cells,
HAdV-D37 appears to rely largely on lipid raft mediated,
caveolin-1 associated endocytosis. Cholera toxin B subunit
(CTXB) has been shown to bind glycosphingolipid ligand, GM1,
and has been used to identify distinct, lipid raft endocytic
pathways [87]. In our study, CTXB co-localized with HAdV-D37
in corneal cells during entry. We show the presence of viral
DNA predominantly in caveolin-1 associated membrane
fractions. It is important to acknowledge that clathrin-mediated
endocytosis is also sensitive to acute depletion of cholesterol
[58,88] and that raft recruitment has been shown to precede
clathrin-dependent endocytosis for anthrax toxin, EGFR, and
BCR, respectively [89–91]. In our study, cholesterol depletion
also reduced viral DNA in LAMP1 rich fractions in corneal cells,
indicating a similar redundancy in cholesterol function. When
cholesterol was replenished in cells treated with MβCD, there
Figure 5.  The role of caveolin-1 and Src kinase in HAdV entry and inflammation.  A. C57BL/6J wild type (WT) and caveolin-1
-/- mice (on the C57BL/6J background) were injected intrastromally with Cy3-labeled (red) HAdV-D37 (105 tissue culture infectious
doses) or buffer control, and the corneas harvested for confocal microscopy. Phalloidin (green) co-staining was used to better
visualize the cells. Virus entry was apparent by 1 hr post infection in WT mice. In caveolin-1 -/- mice, virus remained mostly
membrane bound in the first hour post infection and internalization appeared reduced at 24 hr compared to WT mice. B. Western
blot analysis of the cornea from mice infected with HAdV-D37 revealed increasing pSrc at 1 and 24 hr post infection, while
expression was minimal in untouched (uninfected) corneas. Caveolin-1 -/- mice did not show increased pSrc even after 24 hr
infection. Actin controls are shown in the bottom panel. C. ELISA for CXCL1 chemokine performed on WT and caveolin-1 -/- mice
corneas at 24 hr post infection with HAdV-D37. Infected caveolin-1 -/- mice corneas showed approximately 60% less CXCL1
expression as compared to infected wild type corneas (*p=.0001). Mock infected mice corneas did not produce any detectable
CXCL1. D. Histology of PP2 or DMSO (control) pretreated corneas at 4 days post infection with HAdV-D37 or buffer control shows a
reduction of keratitis with chemical inhibition of Src kinase. E. CXCL1 expression by ELISA of HAdV-D37 infected or mock infected
corneas at 16 hr post infection pretreated with the Src kinase inhibitor PP2 (10 μM) or DMSO control demonstrates a significant
reduction in chemokine expression due to Src inhibition (*p<0.05).
doi: 10.1371/journal.pone.0077462.g005
HAdV Entry and Caveolin-1
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Figure 6.  HAdV-37 enters human corneal fibroblasts through caveolin-1 containing, membrane associated
vesicles.  Human corneal fibroblasts were fixed in 2 % paraformaldehyde and the fixed, dehydrated cell pellet embedded and
sectioned at 70-90 nm. Specimens were stained with uranyl acetate and Sato’s lead stain, and viewed by transmission electron
microscopy. A. Photo-electron micrograph of cell membrane demonstrates multiple flask shaped vesicles resembling caveolae (1),
and the formation of a cavesome-like structures (2). B-D. After 30 min of absorption at 4°C, and 30 min incubation at 37°C, virus
can be seen within similar structures (3), and in some cases within what appear to be early or late fusions of caveolae to form
caveosomes (4). Immunoelectron microscopy for caveolin-1 (E, F) was performed on cells infected as above, but treated with 2.3 M
sucrose in PBS for 15 min, frozen, and sectioned at -120° C at 50-80 nm thickness. After immunostaining, protein-A nanogold was
visualized by electron microscopy. (E) Uninfected cells stained for caveolin-1 demonstrate binding of 10 nm gold particles to flask-
shaped vesicles. (F) After virus infection, virus (arrows) can be seen within vesicles also associated with gold particles. Scale bar =
500 nm.
doi: 10.1371/journal.pone.0077462.g006
HAdV Entry and Caveolin-1
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was a gain in entry as determined by confocal microscopy and
viral DNA expression. We also previously showed the critical
role of Src in HAdV infection [35,52,66,67,92]. The observation
of increased Src kinase activity specifically in caveolin-1
enriched fractions in infected cells strongly suggests a role for
caveosomal signaling upon viral infection. At 1 hr post
infection, PP2, a chemical inhibitor of Src kinases, partially
reduced viral entry, whereas both MβCD and RGD more
completely blocked viral entry. Using a mouse keratitis model
[63], caveolin-1-/- mice showed reduced entry of virus as
compared to wild type mice and showed reduced levels of both
pSrc and CXCL1 expression complimenting our in vitro data.
Taken together, these findings suggest a role for Src kinase in
the caveosome during viral entry, with downstream effects on
chemokine expression by infected cells.
Viruses even within the same virus family can utilize different
endocytic pathways, and there may be extensive cross talk
between pathways. For example, within the polyomaviruses,
JC virus enters cells via clathrin mediated endocytosis [93] and
is later sorted into caveosomes [94], while BK virus uses pH
dependent caveolar endocytosis [95]. Other polyomaviruses
enter cells using uncoated vesicles independently of both
caveolin and clathrin [96]. These studies do not account for
potential differences in cell types used to determine viral entry.
Our ultrastructural studies confirm the association between
HAdV-D37 with caveolin-1 in corneal fibroblasts during viral
entry, but not clathrin in the same cells. Our data also suggests
that HAdV-D37 may utilize different entry pathways in different
cell types. Time course studies with a panel of cell types
relevant to corneal infection will be necessary to determine the
range of entry mechanisms utilized by HAdV-D37, and to better
understand the infectious and inflammatory outcome of
different entry pathways. HAdV-D37 replicates readily in
human corneal fibroblasts [53], and in our hands, knockdown of
caveolin-1 reduced chemokine expression, suggesting that
caveolin contributes to both productive infection and corneal
inflammation. However, our data may be relevant only to the
earliest stages of infection, and does not address possible
sorting of virus later in infection to different endosomal
compartments.
In summary, we have shown that HAdV-D37 enters corneal
stromal cells via a caveolin-1 associated, lipid raft specific
pathway, inducing caveosomal signaling and expression of pro-
inflammatory mediators. Lipid raft mediated endocytosis may
prove a useful target for antiviral therapy in corneal infection.
Experimental Methods
Ethics Statement
The animals involved in this study were procured,
maintained, and used in accordance with the Laboratory
Animal Welfare Act of 1966, as amended and NIH 80-23,
Guide for the Care and Use of Laboratory Animals, National
Research Council, and upon approval from the Animal Care
Committee at the Mass. Eye and Ear Infirmary. The derivation
of corneal cells from deceased human donors was approved by
the Massachusetts Eye and Ear Infirmary Human Studies
Committee, and conformed to the tenets of the Declaration of
Helsinki; written informed consent for the use of the corneas
from the deceased donors or their families was deemed
unnecessary by the Human Studies Committee, because the
corneal tissues arrived without identifying data, and were
tissues that were found by the eye banks to be unsuitable for
corneal transplantation and would have been discarded if not
used in research.
Cells and virus
Primary human corneal fibroblasts were derived from human
donor corneas as previously described [97]. Cells from multiple
deceased donors from multiple eye banks were pooled and the
cell monolayers used at passage two or three. The A549 cells
and HAdVs used in this study were purchased from American
Type Culture Collection (ATCC, Manassas, VA). Virus
purification was performed by cesium chloride gradient. Cy3-
labeled virus was prepared as previously described [98].
Mice
Eight to 12-week-old wild type C57BL/6J and caveolin-1 -/-
mice were obtained from Jackson Laboratories (Bar Harbor,
ME). For experimental infection, female mice were
anesthetized by intramuscular injection of ketamine (85 mg/kg)
and xylazine (14 mg/kg). Anesthetic drops (0.5% proparacaine
hydrochloride, Alcon, Fort Worth, TX) were applied topically to
the right cornea, followed by injection with 1 μl PP2 (10 μM),
DMSO carrier, and then HAdV-37 after 1 hour. One μl of virus
(105 tissue culture infective dose (TCID)), or virus-free dialysis
buffer was injected into the central corneal stroma with a glass
micropipette needle fitted with a gas-powered microinjection
system (MDI, South Plainfield, NJ) under an ophthalmic
surgical microscope (Carl Zeiss Meditec, Inc., Thornwood, NY).
At 4 days post infection, mice were euthanized using CO2
inhalation prior to removal of corneas for histology.
Confocal Microscopy
Cells grown on slide chambers (Nunc, Rochester, NY) were
treated with MβCD (5mM; Sigma, St. Louis, MO), RGD 15-mer
(50mM, GenScript, Piscataway, NJ ), KGE 15-mer (50mM,
GenScript, Piscataway, NJ) or PP2 (10 μM, Calbiochem, La
Jolla, CA) for 1 hr, and then infected with Cy3-labeled HAdV for
30 min and 1 hr. Cells were partially fixed in 0.05%
paraformaldehyde for 10 min, washed in PBS containing 2%
FBS, and permeabilized in solution containing 0.1% Triton
X-100 for 5 min. After 30 min blocking in 3% FBS-PBS, the
cells were incubated in 5 μg/ml of Alexa Fluor 488 phalloidin
(Invitrogen, Eugenia, OR) for 30 min at room temperature,
washed three times in 1x PBS containing 2% FBS. Cells were
then fixed in 2% paraformaldehyde, and mounted using
Vectashield (Vector labs, Burlingame, CA) mounting medium
containing DAPI. Images were taken in a Leica SP5 confocal
microscope using a 63x glycerol immersion objective. Mouse
corneas were harvested at various time points after HAdV-D37
injection and stained with Alexa Fluor 488 phalloidin,
(Invitrogen), fixed, and mounted using Vectashield. For co-
localization studies after infection, cells were fixed and stained
with antibodies to caveolin-1, (Santa Cruz Biotechnology, CA)
LAMP1, (Santa Cruz Biotechnology), or 488-CTXB, (Invitrogen,
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OR). Individual confocal image stacks were loaded to measure
co-localization pixels by Amira 5.2.2 (Amira, Burlington, MA)
from cells stained green (caveolin-1 or LAMP1) and red (Cy3-
labeled HAdV-D37). Three frames each from 3 separate
experiments were chosen in masked fashion and, used to
generate mean and standard deviation.
Non-detergent isolation of lipid rafts
Cells were treated with MβCD, washed thoroughly, and
infected with purified HAdV at a multiplicity of infection (MOI) of
10 for 30 min or mock treated with dialysis buffer. After
infection, LR fractions were isolated using detergent free
methods. Briefly, cells were washed once in ice cold PBS,
suspended in 500mM Na2CO3, and lysed by 20 strokes in a
prechilled dounce homogenizer. Further disruption of cell
membranes were achieved by passing the lysate through a 23
gauge needle 5 times, followed by 3 cycles of sonication for 15
s. The subsequent lysate was mixed with an equal volume of
90% sucrose-MBS (25mM MES{2-(N-
morpholinoethanesulfonic acid) plus 0.15M NaCl [pH 6.5]),
overlaid on an equivalent volume of 35% sucrose-MBS-
Na2CO3, and centrifuged for 16-18 hr at 4°C. 500μl fractions
were collected and the protein concentrations measured. The
lysates were immunoblotted with anti-pSrc (Cell Signaling,
Danvers, MA) to identify phosphorylated Src in LR along with
the LR marker caveolin-1.
Endosome isolation
Flotation gradient fractionation of post nuclear supernatants
was performed with 62%,(2.351M) 35%, (1.177M) and 25%,
(0.806M) sucrose gradients [55] and 100 μl fractions collected.
One hr post HAdV infection after pretreatment with MβCD
(5mM), untreated controls and mock infected cells were
collected and post nuclear supernatants were prepared by
using NucBuster (Novagen, Germany). Post nuclear
supernatants were then mixed with an equal amount of 62%
sucrose, layered over with 1.5 volume of 35% sucrose and 1
volume of 25% sucrose, and centrifuged for 1 hr at 149,000 x g
at 4°C. A series of 100 μl fractions were collected from the
surface and subjected to western blot analysis for caveolin-1,
phosphorylated Src, RAB5, and LAMP1 (Santa Cruz
Biotechnology), and real-time PCR for the HAdV-D37 E1A
gene in order to determine the presence of viral DNA in the
endosomes.
siRNA construction and transfection
The siRNA for caveolin-1 and its control scrambled siRNA
(Table 1) were constructed using SciTools from Integrated
DNA Technology (IDT, Coralville, IA). One nm was transfected
using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA)
following the manufacturer’s instructions. At 48 hr post
transfection, cells were infected with HAdV for 2 hr, and then
analyzed for caveolin-1 and IL-8 message using real-time RT-
PCR (Table 1). For Western blot analysis, 20 μg of protein was
separated in a 4-20% gradient gel (Invitrogen) and
immunoblotted with antibodies against caveolin-1 and actin
(Thermo Scientific, Pittsburgh, PA), the latter as an internal
control.
Real-time PCR
To quantify the presence of viral DNA in endosomal
compartments, the E1A gene was amplified from endosomal
fractions after sucrose gradient with primers (IDT, Table 1)
designed based on the HAdV-D37 genomic E1A nucleotide
sequence [54]. Real-time PCR was performed with Fast SYBR
Green master mix (Applied Biosystems, Foster City, CA) with
the following conditions, 40 cycles at 95°C (10 s), 55°C (20 s),
and a final extension at 72°C for 10 min. To determine mRNA
expression for caveolin-1 and IL-8, total RNA was extracted
from caveolin-1 or scrambled siRNA transfected, HAdV-D37
infected cells, at 2 hr post-infection using TRIzol (Invitrogen)
according to the manufacturer’s instructions. Total RNA was
then treated with DNase I (1 unit) (New England BioLabs,
Ipswich, MA) at 37°C for 1hr. Two μg of the DNase treated
RNA was subjected to reverse transcription with M-MLV
reverse transcriptase (Promega, Madison, WI) and oligo dT15
primers (IDT). Primers for caveolin-1 and IL-8 were designed
using Primer3 plus software (http://www.bioinformatics.nl/cgi-
bin/primer3plus/primer3plus.cgi), and synthesized by IDT
(Table 1). The cDNAs were diluted by 1:10 and 1 µl was used
for qRT-PCR using Fast SYBR Green master mix under the
conditions: 40 cycles oat 95°C (30 s), 60°C (1 min), 72°C (30
s), and a final extension at 72°C for 10 min. A non-template
control and endogenous control (human GAPDH) were
measured for the relative quantification. The related expression
levels were calculated by the 2-ΔΔCT method against the
untransfected/uninfected controls [99].
Src kinase assay
Src activity assays were performed by using ProFluor® Src-
Family Kinase Assay (Promega, Madison, WI). One microgram
of each endosomal fractions (peptide substrate) and 25 μl of
100 μM ATP was added to the reaction buffer and incubated
for 60 min at room temperature, followed by the addition of
protease reagent for another 60 min at room temperature. The
reaction was then stopped by addition of stabilizer reagent.
When there is no kinase activity, the peptide substrate remains
nonphosphorylated, and the protease will remove all amino
acids from the peptide substrate and liberate the highly
Table 1. Nucleotide sequences for siRNA and PCR.
siRNA Sense Sequences Antisense Sequences
Caveolin-1
siRNA
rCrCrA rUrCrU rArCrG rUrCrC
rArCrA rCrCrG rUrCrU rGrUG A
rUrCrA rCrArG rArCrG rGrUrG
rUrGrG rArCrG rUrArG rArUrG
rGrArA
Caveolin-1
scRNA
rGrGrU rArCrA rGrGrC rGrArU
rGrArA rUrArG rGrUrC rGrGrC
rU
rArGrC rCrGrA rCrCrU rArUrU
rCrArU rCrGrC rCrUrG rUrArC rC
PCR Forward Primers Reverse Primers
E1A TTCCTCCCAGCGATTCAGAG GGGCACCTCAGGATTGTCC
Caveolin-1 GGGCATTTACTTCGCCATTC ACGGTGTGGACGTAGATGGA
IL-8 TGCAGCTCTGTGTGAAGGTG ATTTCTGTGTTGGCGCAGTG
GAPDH TGGGCTACACTGAGCACCAG ACCACCCTGTTGCTGTAGCC
doi: 10.1371/journal.pone.0077462.t001
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fluorescent rhodamine 110 (R110). In the presence of active
kinase, the peptide substrate will be phosphorylated, effectively
blocking the protease activity and resulting in low fluorescence
of the Src-Family Kinase R110 substrate. The resulting
fluorescence is read at excitation wavelength 485 and emission
wavelength of 530 nm.
ELISA
Mouse corneas were removed at 16 hr post infection (n = 3/
group). Corneas were then homogenized in 400 µL of PBS with
1 mM phenylmethylsulfonyl fluoride (PMSF), 1 µg/mL aprotinin,
and 10 µg/mL leupeptin (Sigma-Aldrich, St. Louis, MO). The
lysates were centrifuged at 10,000 x g for 10 minutes at 4°C,
and the supernatants were used for ELISA. Mouse CXCL1
(KC) (R&D Systems, Minneapolis, MN) protein detection was
performed with commercially available sandwich ELISA kits
with capture and detection antibodies, according to the
manufacturer’s instructions. Each sample and standard was
analyzed in duplicate. The plates were read on a microplate
reader (Molecular Devices, Sunnyvale, CA) and analyzed
(SOFTmax; Molecular Devices).
Histopathology
Upon euthanasia at 4 d post infection, mouse corneas were
removed surgically, rinsed in PBS, and fixed with 10% neutral
buffered formalin for 24 hr at room temperature. After paraffin
embedding, whole eyes were cut into 5-μm-thick sections,
mounted on positively charged slides and air dried overnight.
After deparaffinization and rehydration, slides were stained with
hematoxylin and eosin for histology, coverslipped, and
photographed (Axiovert 135; Carl Zeiss Meditec, Inc.), using a
40× objective.
Electron Microscopy
Human corneal fibroblasts plated on 10 cm dishes and
grown to 95% confluence were infected with cesium chloride
purified HAdV-D37 virus at a MOI of 10, and incubated at 30
min at 4° C, followed by incubation at 37° C for 30 min. The
cells were then washed with PBS, and fixed in 2 %
paraformaldehyde containing 2.5 % gluteraldehyde, 0.1 M
cacodylate and 2.5 mM CaCl2 for 1 hr, and harvested in 2 %
agarose. The cell pellet was fixed for 1.5 hr in 2 % aqueous
OsO4, and dehydrated. Following dehydration, the cell pellet
was embedded in epon and sectioned at 70-90 nm. The
specimens were stained with saturated aqueous uranyl
acetate, and Sato’s lead stain. Photomicrographs were taken
on a Philips CM-10 electron microscope (Koninklijke Philips
Electronics N.V., Amsterdam, Netherlands) operating at 80 kv
and fitted with a CCD camera.
Immunogold Electron Microscopy
For immunostaining, cells were adsorbed with purified HAdV-
D37 or mock infected with buffer for 30 min at 4° C, followed by
incubation at 37° C for 30 min, washed in PBS, fixed in 4%
paraformaldehyde for 1 hr, and harvested. Cells were treated
with 2.3 M sucrose in PBS for 15 min, frozen and sectioned at
-120° C at 50-80 nm thickness, and transferred to formvar-
carbon coated copper grids. Grids were blocked with 1% BSA
for 10 min and incubated for 30 min with 5 µl of rabbit
polyclonal caveolin-1 antibody, (BD Biosciences, San Jose,
CA) at 25 µg/ml in 1% BSA, followed by wash in PBS, and
incubation with protein-A nanogold (Cell Microscopy Center,
Department of Cell Biology, University Medical Center, Utrecht,
The Netherlands) [100] with a particle size of 10 nm, for 20
min. Alternate sections were stained with mouse IgG1 raised
against rat clathrin heavy chain (BD Biosciences) followed by
rabbit antiserum to mouse IgG (ICN Biomedicals, Irvine, CA) at
1:100 dilution, followed by protein-A nanogold with a particle
size of 5 nm. Protein-A nanogold was incubated for 20 min
followed by washing in PBS, and a final wash with double
distilled water. Grids were then stained in 0.3% uranyl acetate
in 2% methyl cellulose for 10 minutes and photomicrographed
in the electron microscope.
Statistical analysis
Comparisons of means were performed with ANOVA with
Sheffe’s multiple comparison test, or where appropriate with
Students t test. p<.05 was considered statistically significant.
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